NCT02244125 2025-11-24
PCD
Institut Curie
Phase 2 Completed
Clinical Trials
12 trialsNCT00801216 2024-12-10
SCNSL1
IRCCS San Raffaele
Phase 2 Completed
NCT02043847 2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1 Completed
NCT01141712 2023-01-04
Autologous Transplant in HIV Patients (BMT CTN 0803)
Medical College of Wisconsin
Phase 2 Completed
NCT01516593 2022-08-04
CARMEN
IRCCS San Raffaele
Phase 2 Completed
NCT01660633 2020-04-21
Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation
Acrotech Biopharma Inc.
Phase 2 Completed
NCT00024466 2018-09-19
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT00504764 2014-10-28
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
PETHEMA Foundation
Phase 4 Completed
NCT01716793 2012-11-01
Risk-adapted Therapy for Adult Acute Myeloid Leukemia.
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Phase 2 Completed
NCT01112189 2011-03-24
SCL
Hospital Universitario Dr. Jose E. Gonzalez
Phase 1/2 Completed
NCT00560053 2008-11-27
Pethema Multiple Myeloma 2000
PETHEMA Foundation
Phase 3 Completed
NCT00140569 2005-09-01
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
Lymphoma Study Association
Phase 3 Completed